Agenus (AGEN) News Today $4.47 -0.31 (-6.49%) Closing price 06/18/2025 04:00 PM EasternExtended Trading$4.41 -0.06 (-1.34%) As of 06/18/2025 06:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock AGEN Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Agenus and Noetik Enter Collaboration to Develop AI-Enabled Predictive Biomarkers for BOT/BAL Using Foundation Models of Virtual Cell BiologyJune 17 at 7:30 AM | businesswire.comAgenus Inc. (AGEN) Surges After Zydus Agreement, Analysts Upbeat on StockJune 16 at 4:23 PM | insidermonkey.comAnalysts Set Agenus Inc. (NASDAQ:AGEN) Target Price at $14.00June 12, 2025 | americanbankingnews.comAgenus Announces Virtual Annual Shareholders MeetingJune 10, 2025 | businesswire.comAgenus Inc. (NASDAQ:AGEN) Receives Consensus Rating of "Hold" from AnalystsShares of Agenus Inc. (NASDAQ:AGEN - Get Free Report) have been given an average recommendation of "Hold" by the six analysts that are presently covering the firm, MarketBeat Ratings reports. Four analysts have rated the stock with a hold recommendation and two have given a buy recommendation to tJune 9, 2025 | marketbeat.comAgenus Inc (AJ8.MU)June 8, 2025 | ca.finance.yahoo.comFY2027 Earnings Forecast for Agenus Issued By William BlairAgenus Inc. (NASDAQ:AGEN - Free Report) - Investment analysts at William Blair lifted their FY2027 earnings estimates for shares of Agenus in a research note issued to investors on Wednesday, June 4th. William Blair analyst M. Phipps now anticipates that the biotechnology company will earn ($2.21June 6, 2025 | marketbeat.comHC Wainwright Forecasts Agenus' Q3 Earnings (NASDAQ:AGEN)Agenus Inc. (NASDAQ:AGEN - Free Report) - Stock analysts at HC Wainwright raised their Q3 2025 EPS estimates for shares of Agenus in a report issued on Wednesday, June 4th. HC Wainwright analyst E. Bodnar now forecasts that the biotechnology company will earn $0.25 per share for the quarter, up fJune 6, 2025 | marketbeat.comBaird Lifts Agenus (AGEN) PT to $6, Maintains Neutral RatingJune 5, 2025 | msn.comH.C. Wainwright Upgrades Agenus (AGEN) Stock to BuyJune 4, 2025 | insidermonkey.comAnalyst Upgrades Agenus As Zydus Deal Alleviates Cash OverhangJune 4, 2025 | benzinga.comH.C. Wainwright Upgrades Agenus (AGEN) Stock to BuyJune 4, 2025 | msn.comAnalyst Upgrades Agenus As Zydus Deal Alleviates Cash OverhangJune 4, 2025 | benzinga.comAgenus and Zydus Lifesciences Enter $141M Strategic Collaboration to Advance BOT/BAL, Expand Zydus' Biologics Manufacturing in the USJune 4, 2025 | tmcnet.comAgenus and Zydus sign agreements for botensilimab and balstilimabJune 4, 2025 | finance.yahoo.comAgenus (NASDAQ:AGEN) Price Target Raised to $6.00 at Robert W. BairdRobert W. Baird increased their target price on Agenus from $4.00 to $6.00 and gave the stock a "neutral" rating in a research note on Wednesday.June 4, 2025 | marketbeat.comAgenus (NASDAQ:AGEN) Upgraded by HC Wainwright to Buy RatingHC Wainwright raised shares of Agenus from a "neutral" rating to a "buy" rating and set a $25.00 price target for the company in a research note on Wednesday.June 4, 2025 | marketbeat.comStrategic Collaboration Between Agenus and Zydus Lifesciences Boosts Financial Position and Product DevelopmentJune 4, 2025 | tipranks.comAgenus, Zydus Lifesciences Enter $141 Million DealJune 4, 2025 | marketwatch.comIndian shares set to open higher on hopes of easing global trade woesJune 4, 2025 | msn.comZynext Ventures acquires stake in Agenus, expands its immuno-oncology pipeline and global reachJune 4, 2025 | finance.yahoo.comAgenus climbs on deal with India’s Zydus for cancer therapy BOT/BALJune 4, 2025 | msn.comJane Street Group LLC Raises Stock Position in Agenus Inc. (NASDAQ:AGEN)Jane Street Group LLC lifted its stake in shares of Agenus Inc. (NASDAQ:AGEN - Free Report) by 97.6% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 105,705 shares of the biotechnology company's stock after buying an additionalJune 4, 2025 | marketbeat.comAgenus Stock Is Trading Higher Tuesday: What's Going On?June 3, 2025 | benzinga.comAgenus and Zydus Lifesciences Enter $141M Strategic Collaboration to Advance BOT/BAL, Expand Zydus’ Biologics Manufacturing in the USJune 3, 2025 | financialpost.comAgenus Presents New Data at ASCO Highlighting Botensilimab’s Immune Activation in MSS Colorectal CancerMay 30, 2025 | finance.yahoo.comAgenus Presents New Data at ASCO Highlighting Botensilimab's Immune Activation in MSS Colorectal CancerMay 30, 2025 | businesswire.comAgenus (NASDAQ:AGEN) Share Price Passes Above 200-Day Moving Average - Should You Sell?Agenus (NASDAQ:AGEN) Stock Price Crosses Above 200-Day Moving Average - What's Next?May 28, 2025 | marketbeat.comAgenus (NASDAQ:AGEN) Upgraded to Hold at StockNews.comStockNews.com upgraded shares of Agenus from a "strong sell" rating to a "hold" rating in a research report on Thursday.May 24, 2025 | marketbeat.comAgenus: Big On BOT/BAL As Cash Burn And Catalysts CollideMay 23, 2025 | seekingalpha.comWhat is B. Riley's Estimate for Agenus FY2025 Earnings?Agenus Inc. (NASDAQ:AGEN - Free Report) - Investment analysts at B. Riley raised their FY2025 earnings per share (EPS) estimates for Agenus in a research note issued to investors on Thursday, May 15th. B. Riley analyst M. Mamtani now forecasts that the biotechnology company will post earnings ofMay 21, 2025 | marketbeat.comAgenus Inc. (NASDAQ:AGEN) Receives Average Recommendation of "Hold" from BrokeragesShares of Agenus Inc. (NASDAQ:AGEN - Get Free Report) have received a consensus rating of "Hold" from the six brokerages that are currently covering the firm, MarketBeat Ratings reports. Five investment analysts have rated the stock with a hold recommendation and one has assigned a buy recommendaMay 17, 2025 | marketbeat.comAgenus says expanded MSS mCRC cohort data to be presented at ESMO GIMay 16, 2025 | finance.yahoo.comAgenus Announces New Data from Expanded MSS Metastatic Colorectal Cancer Cohort to be Presented at ESMO GI 2025May 15, 2025 | businesswire.comAgenus (NASDAQ:AGEN) Earns "Neutral" Rating from HC WainwrightHC Wainwright reaffirmed a "neutral" rating on shares of Agenus in a research report on Tuesday.May 15, 2025 | marketbeat.comAgenus (NASDAQ:AGEN) Price Target Raised to $4.00 at Robert W. BairdRobert W. Baird upped their target price on shares of Agenus from $3.00 to $4.00 and gave the stock a "neutral" rating in a research note on Tuesday.May 15, 2025 | marketbeat.comAgenus (NASDAQ:AGEN) Announces Earnings ResultsAgenus (NASDAQ:AGEN - Get Free Report) announced its earnings results on Monday. The biotechnology company reported ($1.03) earnings per share (EPS) for the quarter, beating the consensus estimate of ($1.72) by $0.69.May 14, 2025 | marketbeat.comAgenus appoints oncology veteran Dr. Goldberg as CDOMay 13, 2025 | uk.investing.comQ1 2025 Agenus Inc Earnings CallMay 13, 2025 | finance.yahoo.comQ1 2025 Agenus Inc Earnings Call TranscriptMay 13, 2025 | gurufocus.comAgenus signals near-term strategic transactions and operational cash burn target below $50M amid BOT/BAL data advancesMay 12, 2025 | msn.comAgenus Inc. (AGEN) Q1 2025 Earnings Call TranscriptMay 12, 2025 | seekingalpha.comAgenus (AGEN) Sets Strategic Path with New Leadership and TransactionsMay 12, 2025 | gurufocus.comAgenus Hold Rating: Uncertainty Amid Funding and Regulatory ChallengesMay 12, 2025 | tipranks.comRenowned GI Oncology Leader Dr. Richard Goldberg Joins Agenus as Chief Development Officer | ...May 12, 2025 | gurufocus.comAgenus Reports Q1 2025 Financial Results and Key Business Updates | AGEN Stock NewsMay 12, 2025 | gurufocus.comAgenus Inc (AGEN) Q1 2025 Earnings: EPS Beats Estimates at -$1.03, Revenue Misses at $24.1 MillionMay 12, 2025 | gurufocus.comRenowned GI Oncology Leader Dr. Richard Goldberg Joins Agenus as Chief Development OfficerMay 12, 2025 | gurufocus.comAgenus Reports Q1 2025 Financial Results and Key Business UpdatesMay 12, 2025 | gurufocus.comAgenus (AGEN) Reports Strong Q1 Revenue Surpassing Expectations | AGEN Stock NewsMay 12, 2025 | gurufocus.com Get Agenus News Delivered to You Automatically Sign up to receive the latest news and ratings for AGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address AGEN Media Mentions By Week AGEN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AGEN News Sentiment▼0.100.69▲Average Medical News Sentiment AGEN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AGEN Articles This Week▼26▲AGEN Articles Average Week Get Agenus News Delivered to You Automatically Sign up to receive the latest news and ratings for AGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Myriad Genetics News Zenas Biopharma News Rigel Pharmaceuticals News Emergent BioSolutions News Verastem News XOMA News Vanda Pharmaceuticals News Lexicon Pharmaceuticals News Codexis News Sangamo Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AGEN) was last updated on 6/19/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Agenus Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Agenus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.